Blog

Bio-Techne Go Everywhere Travel Grant - March Recipient Selected!

星期三, 四月 10, 2019 - 07:33
Bio-Techne Travel Grants

Bio-Techne’s Go Everywhere Travel Grant Program awards $1000 USD (or equivalent) to one researcher each month to attend the meeting of their choice. This grant program allows the researcher to attend more targeted meetings in their field and provides funding to support both small and large scientific associations that promote discovery and collaboration.

The recipient of the March 2019 grant is Jorieke Weiden, a Postdoctoral Researcher in the Tumor Immunology department at Radboud University Medical Center in Nijmegen, Netherlands.

Bio-Techne’s ...

Stem Cells in the News - April 2019

星期五, 三月 29, 2019 - 13:46
https://origin-rndsystemsstg.corpenttech.com/blog/stem-cells-news-february-2019Stem Cells in the News

We have captured this month’s most interesting, innovative, and maybe some of the strangest examples of stem cells in the news from around the world.

Nature

A therapy developed at Osaka University received provisional approval for use to treat damaged or diseased corneal...

Cell and Gene Therapies for Cancer: Future Promises and Challenges

星期五, 三月 8, 2019 - 10:25

Featured speakers:

J. Joseph Melenhorst, Ph.D., University of Pennsylvania

Laurence J. N. Cooper, M.D., Ph.D., Ziopharm Oncology

Moderated by:

Sean Sanders, Ph.D., Science/AAAS

The field of immuno-oncology has exploded in the clinic, in the press, and on Wall Street, particularly regarding the use of genetically modified immune cells to fight cancer. This “explosion” is largely due to the success of chimeric antigen receptor (CAR) T-cell therapy. The fields of immunology and gene therapy have converged to harness recombinant viruses to deliver “living drugs” with remarkable clinical efficacy, especially for patients with blood cancers. Multiple approaches to engineer immune cells—mostly T cells but also other immune cell types—make use of CARs, while tumor-specific T-cell receptors continue to gain a foothold...

Stem Cells in the News - March 2019

星期四, 三月 7, 2019 - 09:27
https://origin-rndsystemsstg.corpenttech.com/blog/stem-cells-news-february-2019Stem Cells in the News

We have captured this month’s most interesting, innovative, and maybe some of the strangest examples of stem cells in the news from around the world.

UCSF News

The Kreigstein lab at the University of...

Anti-idiotype Antibodies: Monoclonal Therapeutic Discovery and Development

星期一, 三月 4, 2019 - 16:12
Anti-Idiotype Antibodies

The monoclonal antibody therapy market is rapidly expanding with all major pharmaceutical companies seeking approval of more antibody drug modalities each year. In addition, many of the blockbuster monoclonal therapeutics are nearing the end of their patents and the opportunity for biosimilars looms in the marketplace.

Researchers look to anti-idiotype antibodies to study new monoclonal therapeutic candidates, to better understand the efficacy of existing monoclonal therapeutics and to evaluate the development of biosimilars. An anti-idiotype (anti-ID) antibody is specific to the unique antigen binding (variable) region of another antibody. In this case, the anti-idiotype is specific to the monoclonal therapeutic or its biosimilar.

R...

Bio-Techne Go Everywhere Travel Grant - January Recipient Selected!

星期日, 二月 10, 2019 - 05:27
Bio-Techne Travel Grants

Bio-Techne’s Go Everywhere Travel Grant Program awards $1000 USD (or equivalent) to one researcher each month to attend the meeting of their choice. This grant program allows the researcher to attend more targeted meetings in their field and provides funding to support both small and large scientific associations that promote discovery and collaboration.

The recipient of the January 2019 'Go Everywhere Travel Grant' is Mattia Volta, a Senior Researcher in the Institute for Biomedicine at the Eurac Research in Bolzano, Italy.

Mattia has chosen to apply the grant to attend the World Parkinson Congress 2019 in Kyto, Japan on June 4 – June 7, 2019!

...

Stem Cells in the News - February 2019

星期一, 二月 4, 2019 - 10:44
https://origin-rndsystemsstg.corpenttech.com/blog/stem-cells-news-february-2019Stem Cells in the News

We have captured this month’s most interesting, innovative, and maybe some of the strangest examples of stem cells in the news from around the world.

Stem Cells in the News - January 2019

星期五, 一月 4, 2019 - 08:25
Stem Cells in the News

We have captured this month’s most interesting, innovative, and maybe some of the strangest examples of stem cells in the news from around the world.

Science Daily

Scientists from the German Cancer Research Center have, for the first time, successfully directly reprogrammed human blood cells into...

Bio-Techne Go Everywhere Travel Grant - December Recipient Selected!

星期三, 一月 2, 2019 - 09:26
Bio-Techne Travel Grants

Bio-Techne’s Go Everywhere Travel Grant Program awards $1000 USD (or equivalent) to one researcher each month to attend the meeting of their choice. This grant program allows the researcher to attend more targeted meetings in their field and provides funding to support both small and large scientific associations that promote discovery and collaboration.

The recipient of the December 2018 'Go Everywhere Travel Grant' is Samantha Jones, a PhD Candidate in Medical Genetics at the University of British Columbia, in Vancouver, British Columbia, Canada. Samantha has chosen to apply the grant to attend the 25th Biennial Congress of the European Association for Cancer Research in Amsterdam, the Netherlands on...

Bio-Techne Go Everywhere Travel Grant - November Recipient Selected!

星期日, 十二月 2, 2018 - 13:27
Bio-Techne travel grants

November 2018 Go Everywhere with Bio-Techne Travel Grant Awarded to PhD Student from the University of Liverpool!

Bio-Techne's Go Everywhere Travel Grant Program awards $1000 USD (or equivalent) to one researcher each month to attend the meeting of their choice. This grant program allows the researcher to attend more targeted meetings in their field and provides funding to support both small and large scientific associations that promote discovery and collaboration.

The recipient of the November 2018 grant is Anna Glaser, a PhD Student in the Women's and Children's Health department at the University of Liverpool in Liverpool, United Kingdom!

...

Stem Cells in the News - December 2018

星期五, 十一月 30, 2018 - 11:01
Stem Cells in the News

We have captured this month’s most interesting, innovative, and maybe some of the strangest examples of stem cells in the news from around the world.

Bio-Techne Go Everywhere Travel Grant - October Recipient Selected!

星期六, 十一月 10, 2018 - 09:44
Bio-Techne Travel Grants

Bio-Techne’s Go Everywhere Travel Grant Program awards $1000 USD (or equivalent) to one researcher each month to attend the meeting of their choice. This grant program allows the researcher to attend more targeted meetings in their field and provides funding to support both small and large scientific associations that promote discovery and collaboration.

The recipient of the October 2018 grant is Lahiru Gangoda, an Honorary Research Fellow in the Biochemistry and Genetics department at La Trobe University in Melbourne, Australia!

Lahiru has chosen to apply the grant to attend the Lorne Cancer Conference 2019 in Lorne, Australia on February 14 -16, 2019.

She is conducting her current...

Stem Cells in the News - November 2018

星期三, 十月 31, 2018 - 10:02
Stem Cells in the News

We have captured this month's most interesting, innovative, and maybe some of the strangest examples of stem cells in the news from around the world.

Drug Target Review

Researchers at the University of Colorado Cancer Center have found the upregulation of CDK1 and its direct interaction with Sox2 play a crucial role in the development...

Stem Cells in the News - October 2018

星期一, 十月 8, 2018 - 13:37
Stem Cells in the News

We have captured this month's most interesting, innovative, and maybe some of the strangest examples of stem cells in the news from around the world.

Bio-Techne Go Everywhere Travel Grant – September 2018 Recipient Selected!

星期二, 十月 2, 2018 - 14:27
Bio-Techne travel grants

September 2018 Go Everywhere with Bio-Techne Travel Grant Awarded to a Research Associate from Wayne State University!

Bio-Techne's Go Everywhere Travel Grant Program awards $1000 USD (or equivalent) to one researcher each month to attend the meeting of their choice. This grant program allows the researcher to attend more targeted meetings in their field and provides funding to support both small and large scientific associations that promote discovery and collaboration.

The recipient of the September 2018 grant is Dr. Samaresh Sau, a Research Associate in the Pharmaceutical Science department at Wayne State University in Detroit, Michigan (USA).

...

Utilizing Extracellular Matrix to Enhance Multicellular Tumor Spheroid Models for Proliferation and Invasion

星期五, 九月 21, 2018 - 08:47

This technical video provides an overview of the methodologies, tools, and reagents used to generate multicellular tumor spheroids. Specifically, this video discusses the benefits of Cultrex® extracellular matrices for spheroid formation and analysis. Technical tips are provided for using colorimetric and fluorometric assays to evaluate cell proliferation and invasion of spheroids.

This protocol video was originally recorded by Dr. Gabriel Benton at Trevigen, Inc. The Trevigen portfolio, including tools for creating 3-D and spheroid cultures, are now a part of R&D Systems, a Bio-Techne brand.

In this technical video you will learn:

  • Evolution of extracellular matrices used for 3-D cell culture
  • Benefits and challenges of spheroid models
  • Methods for spheroid formation
  • Tips...

Stem Cells in the News – September 2018

星期五, 八月 31, 2018 - 09:30
Stem Cells in the News

We have captured this month's most interesting, innovative, and maybe some of the strangest examples of stem cells in the news from around the world.

EurekaAlert!

A new study published in Tissue Engineering this month suggests that platelet-rich-plasma (PRP) does not promote or enhance...

R&D Systems Website Enhancements

星期二, 八月 14, 2018 - 13:20
New website enhancements

We are excited to launch new changes to the R&D Systems site! The site has new functionality and design to enhance the overall customer experience.  Some changes that you will see on the site:

  • Responsive Layout: The website will size appropriately to the device that you are using, including desktop computers, mobile phones, and tablets.
     
  • Datasheets/Product Data Pages: A new layout for the entire page for all the tabs and sections. You can filter product reviews, find related products and scroll through images in the new lightbox.
     
  • Luminex Assay Customization Tool...

Stem Cells in the News - August 2018

星期五, 八月 3, 2018 - 10:11
Stem Cells in the News

We have captured this month's most interesting, innovative, and maybe some of the strangest examples of stem cells in the news from around the world.

ScienceDaily

Researchers from Osaka University have recently published findings revealing the importance of SATB1 protein in the self-...

Welcome to our Summer Protein Update

星期三, 八月 1, 2018 - 08:19
New Proteins , Webinars and Resources
 

New Products

Recombinant Human DLL3
Recombinant Human DLL3 Now Available
Delta-like protein 3 (DLL3) is a transmembrane protein that belongs to the Delta/Serrate/Lag-2 (DSL) family of Notch ligands. It has received much recent attention due to its potential as a target for small cell lung cancer.
 
...

Webinar Short: CellXVivo™ Kits for the Differentiation or Expansion of Immune Cells

星期三, 七月 11, 2018 - 13:17

Watch this short video highlighting our CellXVivo™ kits developed for the consistent differentiation and expansion of T cells subtypes, dendritic cells, B cells, cytotoxic cells, and more. Kits include buffers, cytokines and optimized protocols for easy and reproducible cell culture.

Learn More About CellXVivo™ Immune Cell Differentiation and Expansion Kits

Recorded June 15, 2018

Bio-Techne Go Everywhere Travel Grant – June 2018 Recipient Selected!

星期日, 七月 8, 2018 - 12:23
Bio-Techne Travel Grants

Bio-Techne’s Go Everywhere Travel Grant Program awards $1000 USD (or equivalent) to one researcher each month to attend the meeting of their choice. This grant program allows the researcher to attend more targeted meetings in their field and provides funding to support both small and large scientific associations that promote discovery and collaboration.

The recipient of the June 2018 grant is Lucy McDermott, a PhD Student in the Nuffield Department of Clinical Neurosciences at the University of Oxford in Oxford, England.

...

Immunology News: Targeting Myeloid-Derived Suppressor Cells (MDSCs) for Cancer Immunotherapy

星期二, 七月 3, 2018 - 08:24
MDSC

Myeloid-derived suppressor cells (MDSCs) are a diverse population of immature myeloid cells with immunosuppressive properties that accumulate under pathological conditions including specific types of cancer and infections. Two primary subsets of human and mouse MDSCs known as granulocytic and monocytic MDSCs have been identified. These cells are of great interest as high levels of circulating MDSCs in cancer patients have been shown to correlate with clinical stage, metastatic burden, and resistance to both chemotherapy and immunotherapy. As a result, MDSCs are now recognized as a major obstacle in the treatment of cancer. Multiple strategies targeting these cells are being investigated to determine if the...

Stem Cells in the News - July 2018

星期一, 七月 2, 2018 - 14:03
Stem Cells in the News

We have captured this month's most interesting, innovative, and maybe some of the strangest examples of stem cells in the news from around the world.

The Scientist

A whistleblower in the misconduct case at the Karolinska...

Validating Antibodies to Support the AstraZeneca Drug Discovery Pipeline

星期一, 七月 2, 2018 - 08:15
Validating Antibodies to Support the AstraZeneca Drug Discovery Pipeline

Antibodies are critical tools in the majority of research and clinical studies. However, unreliable antibodies with poor specificity or reproducibility remain a significant drain on resources across biomedical research and industry. Widespread acceptance of the need for end-user antibody validation has led to high profile initiatives and guidance (e.g. Uhlen et al, Nat. Methods 2016). Aligning to these principles, the AstraZeneca Affinity Reagent Group provides company-wide advice and scientific support in the validation of both commercial and our bespoke antibodies generated in-house. Our work feeds into activities across the drug discovery pipeline, including target identification / validation, hit-...

页面